Search Results

• • 11 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Reply to "PPAR-[gamma] regulates pharmacological but not physiological or pathological osteoclast formation"

  Authors:Ronald M Evans and Yihong WanFrom:Nature Medicine (Vol. 22, Issue 11) Peer-Reviewed

  Nov. 2016990 words Letter to the editor... 1500LAuthor(s): Ronald M Evans (corresponding author) [1]; Yihong Wan [2] Evans and Wan reply: This concerns the correspondence by Zou et al . [1] on the physiologic, pharmacologic and pathologic roles of peroxisome...

• Maternal PPAR [gamma] protects nursing neonates by suppressing the production of inflammatory milk

  Authors:Yihong Wan, Alan Saghatelian, Ling- Wa Chong, Chun-Li Zhang, Benjamin. F. Cravatt, and Ronald M. EvansFrom:Genes & Development (Vol. 21, Issue 15) Peer-Reviewed

  Aug. 1, 200745 words Clinical report

   Abstract Only

• miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

  Authors:Jing Y. Krzeszinski, Wei Wei, HoangDinh Huynh, Zixue Jin, Xunde Wang, Tsung-Cheng Chang, et al.From:Nature (Vol. 512, Issue 7512) Peer-Reviewed

  Aug. 28, 20144,976 words Report 1460LBone-resorbing osteoclasts significantly contribute to osteoporosis and bone metastases of cancer (1-3). MicroRNAs play important roles in physiology and disease (4,5), and present tremendous therapeutic potential (6)....

• Maternal western diet causes inflammatory milk and TLR2/4-dependent neonatal toxicity

  Authors:Yang Du, Marie Yang, Syann Lee, Cassie L. Behrendt, Lora V. Hooper, Alan Saghatelian, et al.From:Genes & Development (Vol. 26, Issue 12) Peer-Reviewed

  June 15, 2012 Report

   Citation Only

• Macrophage PPAR[gamma] inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone

  Authors:Wing Yin Cheng, HoangDinh Huynh, Peiwen Chen, Samuel Pena-Llopis, and Yihong WanFrom:eLife (Vol. 5) Peer-Reviewed

  Oct. 3, 201613,310 words Report 1430LTumor-associated macrophage (TAM) significantly contributes to cancer progression. Human cancer is enhanced by PPAR[gamma] loss-of-function mutations, but inhibited by PPAR[gamma] agonists such as TZD diabetes drugs...

• New therapeutic targets for cancer bone metastasis

  Authors:Jing Y. Krzeszinski and Yihong WanFrom:Trends in Pharmacological Sciences (Vol. 36, Issue 6) Peer-Reviewed

  June 201584 words Article

   Abstract Only

• Gpr132 sensing of lactate mediates tumor--macrophage interplay to promote breast cancer metastasis

  Authors:Peiwen hen, Hao Zuo, Hu Xiong, Matthew J. Kolar, Qian Chu, Alan Saghatelian, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 114, Issue 3) Peer-Reviewed

  Jan. 17, 20176,437 words Report 1450L

   Citation Only

• Molecular determinants for the polarization of macrophage and osteoclast.

  Authors:Dengbao Yang and Yihong WanFrom:Seminars in Immunopathology (Vol. 41, Issue 5) Peer-Reviewed

  Sept. 2019199 words Report, Brief articl...

   Abstract Only

• Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor [gamma]

  Authors:Wei Wei, Paul A. Dutchak, Xunde Wang, Xunshan Ding, Xueqian Wang, Angie L. Bookout, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 109, Issue 8) Peer-Reviewed

  Feb. 21, 2012 Author abstract, Rep...

   Citation Only

• MicroRNA Exert Macro Effects on Cancer Bone Metastasis

  Authors:Scott R. Baier and Yihong WanFrom:Current Osteoporosis Reports (Vol. 14, Issue 5)

  Oct. 2016239 words Report

   Abstract Only

• PPAR-[gamma] regulates osteoclastogenesis in mice

  Authors:Yihong Wan, Ling-Wa Chong, and Ronald M EvansFrom:Nature Medicine (Vol. 13, Issue 12) Peer-Reviewed

  Dec. 20075,607 words Article Author(s): Yihong Wan [1]; Ling-Wa Chong [1]; Ronald M Evans (corresponding author) [1] Osteoclasts are bone-resorbing cells derived from hematopoietic precursors of the monocyte-macrophage lineage. Regulation of...